HRA Pharma introduces Nor Levo

HRA Pharma is introducing a new product, Nor Levo, which will be placed over the counter in Canada in order to provide for the unmet needs of men to have sexual access to underage girls.

This minimally effective levonorgestrel product will, like the other brand, Plan B, provide a false feeling of security that sexual access can be obtained without pregnancy complications. However, since this contraception, in actual practice is no better than the withdrawal method, the demand for abortion is expected to increase, as it has in response to the over the counter presence of Plan B.